Kornitzer Benjamin S, Yao Aaron, Peikes Deborah N, Rao Karthik
Icahn School of Medicine at Mount Sinai, General Internal Medicine, New York, NY 10029, United States.
FastHSR, Glen Allen, VA 23059, United States.
Health Aff Sch. 2025 Apr 30;3(5):qxaf093. doi: 10.1093/haschl/qxaf093. eCollection 2025 May.
Amid growing primary care shortages and increased use of value-based care (VBC), we evaluated whether adopting a multipayer, full-risk VBC model for Traditional Medicare (TM) and Medicare Advantage beneficiaries-supported by an enablement organization-affected primary care providers' (PCPs) acceptance of new patients with TM insurance.
Using a difference-in-differences analysis of 2019-2023 claims, we compared 2 groups of PCPs with at least 50 TM patients in their panels: 208 PCPs who received support to adopt a VBC model for TM and Medicare Advantage patients in 2022, and 3657 similar PCPs who maintained their existing payment models.Between the preadoption period and 2023, access to new patient visits for patients with TM insurance declined more for nonadopters than adopters.
Primary care providers' in the VBC group saw, on average, 8 more new TM patients annually than nonadopters. This change is sizable relative to their 22.6 new TM patients in 2023. Additionally, the VBC group kept their panels open to new patients with TM insurance for 0.7 more months per year, on average, than nonadopters, relative to preadoption.
These findings suggest that a VBC model with support may help sustain access to primary care for TM beneficiaries, even as overall availability declines.
在初级医疗短缺日益严重且基于价值的医疗(VBC)使用增加的背景下,我们评估了在一个赋能组织的支持下,为传统医疗保险(TM)和医疗保险优势计划受益人采用多支付方、全风险VBC模式是否会影响初级医疗服务提供者(PCP)对TM保险新患者的接纳情况。
利用2019 - 2023年索赔数据的差异分析,我们比较了两组在其患者名单中至少有50名TM患者的PCP:208名在2022年获得支持以采用针对TM和医疗保险优势计划患者的VBC模式的PCP,以及3657名维持其现有支付模式的类似PCP。在采用前时期至2023年期间,未采用者中TM保险患者获得新患者就诊机会的下降幅度比采用者更大。
VBC组的初级医疗服务提供者每年平均比未采用者多接待8名新的TM患者。相对于他们在2023年接待的22.6名新TM患者而言,这一变化相当可观。此外,相对于采用前,VBC组每年平均为TM保险新患者开放患者名单的时间比未采用者多0.7个月。
这些发现表明,即使整体可及性下降,得到支持的VBC模式可能有助于维持TM受益人的初级医疗可及性。